Quantitative Immunohistochemistry for the Investigation of Regulatory Peptides in Health and Disease

Immunohistochemical studies often present the problem of quantifying the immunoreactive structures in an objective and reliable way, particularly when examining samples which may present possible changes. The advent of computerized image analysis has made possible the quantitative evaluation of immunoreactive structures identified with chromogenic or immunofluorescent methods. However, there are a number of potential problems which can be encountered during image analysis quantification. Size changes due to fixation shrinkage have been observed during specimen preparation, while tissue cutting can cause compression of the sections. Non-specific tissue autofluorescence can be reduced by the use of counterstaining or filters. Also, during imaging it is important to stabilize the power supply to provide uniform illumination. Video cameras tend to be more light-sensitive at the center of the field than at the edges, resulting in uneven illumination. For analysis, the average image input can be modified by defining a specific area or deleting unwanted signal. Before the image is measured, grey levels need to be defined to discriminate the image intensity, and analysis parameters should be selected. Using quantitative immunohistochemistry, it is possible to provide an accurate assessment of nerve density or of immunostained surface area from images containing a large number of immunoreactive structures. These measurements can be made rapidly.Statistically significant differences may be demonstrated when comparing control, experimental, or pathological tissues.

[1]  I. S. de la Lande,et al.  MODIFICATION OF AUTOFLUORESCENCE IN THE FORMALDEHYDE-TREATED RABBIT EAR ARTERY BY EVANS BLUE , 1968, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[2]  C. Bunker,et al.  Endothelin-1 in human skin: immunohistochemical, receptor binding, and functional studies. , 1991, Journal of cardiovascular pharmacology.

[3]  D. Reis,et al.  Quantitative immunocytochemistry of tyrosine hydroxylase in rat brain. I. Development of a computer assisted method using the peroxidase-antiperoxidase technique , 1982, Brain Research.

[4]  G. Burnstock,et al.  5-HT-containing nerves to major cerebral arteries of the gerbil originate in the superior cervical ganglia , 1986, Brain Research.

[5]  T. Cowen,et al.  Cerebrovascular nerves in old rats show reduced accumulation of 5-hydroxytryptamine and loss of nerve fibres , 1990, Brain Research.

[6]  J. Polak,et al.  The ontogeny and distribution of neuropeptides in the human fetal and infant esophagus. , 1992, Gastroenterology.

[7]  G. D. Johnson,et al.  A simple method of reducing the fading of immunofluorescence during microscopy. , 1981, Journal of immunological methods.

[8]  C. Bunker,et al.  Deficiency of calcitonin gene-related peptide in Raynaud's phenomenon , 1990, The Lancet.

[9]  T. Cowen,et al.  A quantitative study of changes in old age of 5-hydroxytryptamine-like immunoreactivity in perivascular nerves of the rabbit. , 1989, Journal of the autonomic nervous system.

[10]  C. Bunker,et al.  Image analysis quantification of peptide‐immunoreactive nerves in the skin of patients with Raynaud's phenomenon and systemic sclerosis , 1991, The Journal of pathology.

[11]  Quantitative differences in the deposition of βA4 protein in the sulci and gyri of frontal and temporal isocortex in Alzheimer's disease , 1992, Neuroscience Letters.

[12]  C. Bunker,et al.  Calcitonin‐gene‐related‐peptide in the treatment of severe Raynaud's phenomenon , 1989 .

[13]  G. Burnstock,et al.  Image analysis of catecholamine fluorescence , 1982, Brain Research Bulletin.

[14]  Richard E. Coggeshall,et al.  A consideration of neural counting methods , 1992, Trends in Neurosciences.

[15]  G. Burnstock,et al.  Origin and postnatal development of nerves showing 5-hydroxytryptamine-like immunoreactivity supplying major cerebral arteries of the rat , 1987, Neuroscience Letters.

[16]  G. Collina,et al.  Increased intracellular levels of calcitonin gene‐related peptide‐like immunoreactivity in pulmonary endocrine cells of hypoxic rats , 1988, The Journal of pathology.

[17]  Robert N. Holdefer,et al.  Quantitative immunocytochemistry using an image analyzer. I. Hardware evaluation, image processing, and data analysis , 1988, Journal of Neuroscience Methods.

[18]  M. Roth,et al.  The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.

[19]  G. K. Wilcock,et al.  Plaques, tangles and dementia A quantitative study , 1982, Journal of the Neurological Sciences.

[20]  J. Polak,et al.  Quantitative immunocytochemistry shows calcitonin gene-related peptide-like immunoreactivity in lung neuroendocrine cells is increased by chronic hypoxia in the rat. , 1990, American journal of respiratory cell and molecular biology.